Choline Fenofibrate SR Pellets Manufacturer in India

Choline Fenofibrate SR Pellets – Pharmaceutical-Grade Sustained-Release Pellets

Choline Fenofibrate SR Pellets are pharmaceutical-grade sustained-release multiparticulate pellets containing Choline Fenofibrate as the active ingredient. Choline Fenofibrate is the choline salt of fenofibric acid and has CAS Number 856676-23-8, molecular formula C₂₂H₂₈ClNO₅, and molecular weight 421.91 g/mol. USP defines Choline Fenofibrate as containing 97.0%–103.0%, calculated on the anhydrous basis.

The sustained-release pellet format is designed to provide controlled release of the active ingredient over an extended period. The release profile can be regulated through suitable matrix or functional coating technology, with the final performance depending on active loading, pellet size, coating characteristics and formulation composition.

Choline Fenofibrate is a relatively specialized pharmaceutical ingredient, and reliable public documentation for a universal commercial strength specifically for Choline Fenofibrate SR Pellets is limited. Therefore, an unsupported pellet percentage should not be added to the SDP page. The exact active loading should be taken from the current SDP specification or COA.

Choline Fenofibrate SR Pellets can be positioned for multiparticulate oral formulation development, capsule filling, sustained-release formulation manufacturing and bulk pharmaceutical supply. Product-specific specifications should define assay, moisture, impurities, pellet-size distribution and dissolution/release requirements.

Key Features

• Pharmaceutical-grade Choline Fenofibrate SR Pellets
• Active ingredient: Choline Fenofibrate
• CAS Number: 856676-23-8
• Sustained-release multiparticulate format
• Suitable for oral multiparticulate formulation development
• Suitable for capsule-filling applications
• Product-specific active loading
• Controlled pellet size and physical characteristics
• Product-specific sustained-release dissolution profile
• Suitable for bulk pharmaceutical manufacturing
• Formulation flexibility for modified-release applications

Applications

Sustained-Release Oral Formulations

Choline Fenofibrate SR Pellets are designed for oral formulations requiring controlled release of the active ingredient.

Capsule Filling

The multiparticulate format is suitable for incorporation into capsule dosage forms according to the selected formulation and active loading.

Multiparticulate Formulation Development

Individual pellets provide a flexible platform for developing sustained-release oral formulations with controlled release characteristics.

Pharmaceutical Manufacturing

The pellets can be used as a formulation intermediate for pharmaceutical manufacturers developing sustained-release products.

Bulk Pharmaceutical Supply

Choline Fenofibrate SR Pellets can be supplied in bulk according to the approved active loading and finished-product quality specification.

Why Choline Fenofibrate SR Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets – Designed for pharmaceutical formulation applications.
• Sustained-Release Format – Developed for a controlled release profile of Choline Fenofibrate.
• Product-Specific Active Loading – Active concentration is defined according to the applicable finished-product specification.
• Multiparticulate Format – Suitable for capsule filling and oral multiparticulate formulations.
• Controlled Pellet Characteristics – Pellet size, moisture, coating/matrix characteristics and dissolution can be controlled according to the approved specification.
• Formulation Flexibility – Suitable for sustained-release formulation development.
• Bulk Pharmaceutical Supply – Suitable for pharmaceutical manufacturers requiring bulk pellet intermediates.
• Choline Fenofibrate Pellet Supplier Support – Product and supply parameters can be aligned with customer formulation requirements.

Get Bulk Quote via WhatsApp